Gardenia Cheung-Lau - Concepedia

Concepedia

Author

Gardenia Cheung-Lau

University of California, Los Angeles

Also Known As

G. Cheung-Lau, Gardenia C. Cheung-Lau, Gardenia Cheung-Lau

49

Publications

1.1K

Citations

13

H-Index

52

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Parker Institute for Cancer Immunotherapy

GC

About

Gardenia Cheung-Lau is an author at University of California, Los Angeles specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	695
2	Cell Biology	3	3	156
3	Social Sciences	1	1	110
4	Cellular Physiology	1	1	18
5	Endocrinology	1	1	110

Gardenia Cheung-Lau

×

13

Publications

1.1K

Citations

13

H-Index

	Year	Citations
Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704 Ananya Manuyakorn, Rebecca Paulus, James J. Farrell, Journal of Clinical Oncology Histone ModificationsPathologyCancer BiologyTumor BiologyPancreatic Cancer	2010	220
PAK4 inhibition improves PD-1 blockade immunotherapy Gabriel Abril-Rodríguez, Davis Y. Torrejon, Wei Liu, Nature Cancer Pak4 InhibitionImmunologyTumor ImmunityImmune Checkpoint InhibitorAutoimmunity	2019	154
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar, Cancer Discovery	2020	137
Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide Brian Armstrong, Catalina Abad, Seririthanar Chhith, Neuroscience NeuroregenerationMolecular PhysiologyPituitary GlandMedicinePhysiology	2007	110
Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: A model for the study of intestinal ileus and Hirschsprung's disease Vincent Lelièvre, Géraldine Favrais, Catalina Abad, Peptides Gastrointestinal DysfunctionAutoimmune DiseaseVasoactive Intestinal PolypeptidePathogenesisImmunology	2007	101
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist Giulia Parisi, Justin D. Saco, Felix B. Salazar, Nature Communications	2020	93
A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab Theodore S. Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, Clinical Cancer Research	2018	91
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy Diana C. Márquez‐Garbán, Gang Deng, Begonya Comin-Anduix, The Journal of Steroid Biochemistry and Molecular Biology Breast OncologyBc CellsImmunologyImmunotherapyMammary Gland Development	2019	64
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses Catalina Abad, Yossan‐Var Tan, Gardenia Cheung-Lau, PLoS ONE Inflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationCell Death	2012	28
Vasoactive Intestinal Peptide-Deficient Mice Exhibit Reduced Pathology in Trinitrobenzene Sulfonic Acid-Induced Colitis Catalina Abad, Gardenia Cheung-Lau, Anne-Claire Coûté-Monvoisin, NeuroImmunoModulation	2014	23

Page 1